the First Hospital of China Medical University
Shenyang, Liaoning, 110001, China
NCT Number: NCT03924804
The objective of the trial was to explore the effect of different infusion volume on perioperative bladder and blood volume in patients undergoing daytime surgery assisted by bladder and vascular ultrasound and transthoracic echocardiography.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Shenyang, Liaoning, 110001, China
The objective of the trial was to evaluate the effects of different infusion volume of Ringer's solution acetate (2 ml/kg,8ml/kg, 16ml/kg) on bladder volume, hemodynamics,transthoracic echocardiography and vascular ultrasound including the inferior vena cava(IVC) and the right subclavian vein(SCV) diameter and the IVC and SCV collapsibility index in patients undergoing daytime surgery through a randomized controlled clinical study, so as to provide better guidance for clinical transfusion avoiding bladder catheterization . The patients in this trial were visited before induction and discharge from the postanaesthesia .We also collected the first time and times of micturition and whether the patients have the dysuria.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intravenous infusion of 2 ml/kg Ringer's solution acetate within 1 hour after induction.
Time frame: baseline and 10 minutes before leaving the post-anesthesia care unite
bladder and blood volume in patients undergoing daytime surgery assisted by bladder and vascular ultrasound
China Medical University, China
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05982821
Disease, Endocrine Gland Neoplasms
Guangzhou, Guangdong, China
View Trial DetailsNCT06048575
Biliary Tract Diseases, Cholecystitis
Villavicencio, Meta Department, Colombia
View Trial DetailsNCT04242394
Biliary Tract Diseases, Cholecystitis
Longnan, Gansu, China
View Trial DetailsNCT04463719
Endocrine Gland Neoplasms, Endocrine System Diseases
Gainesville, Florida, United States
View Trial Details